GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
Abstract Exendin-4 is a long acting glucagon-like peptide 1 (GLP-1) analogue that is an agonist for the GLP-1 receptor, a G-protein coupled receptor (GPCR). Exendin-4 is used to clinically improve glucose tolerance in diabetic patients due to its ability to enhance insulin secretion. In rodents, and...
Saved in:
Main Authors: | Joseph Fusco, Xiangwei Xiao, Krishna Prasadan, Qingfeng Sheng, Congde Chen, Yung-Ching Ming, George Gittes |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/adbf0b4c28d74aa08e9ef0b15bfa14d9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activation of the GLP-1 receptor by chloropyrimidine derivatives
by: Shaikha S. AlNeyadi, et al.
Published: (2021) -
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
by: Mette Simone Aae Madsen, et al.
Published: (2019) -
High proliferation and delamination during skin epidermal stratification
by: Mareike Damen, et al.
Published: (2021) -
Targeting GLP-1 receptor trafficking to improve agonist efficacy
by: Ben Jones, et al.
Published: (2018) -
Role and development of GLP-1 receptor agonists in the management of diabetes
by: Chee W Chia, et al.
Published: (2009)